Referencias: Lee KN, Lee OY, Chun HJ, Kim J Il, Kim SK, Lee SW, et al. Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis. World J Gastroenterol. 2022;28(44):6294-309. Velasco JAVR, Morales-Arámbula M, Coss-Adame E, Gómez-Escudero O, Flores-Rendón R, Vázquez-Elizondo G, et al. Prevalencia de sobreposición de trastornos funcionales digestivos: resultados de un estudio nacional (SIGAME 2). Rev Médica MD. 2019;9.10(2):106-12. Simadibrata DM, Lesmana E, Pratama MIA, et al. A systematic review with meta-analysis: Efficacy and safety of potassium-competitive acid blocker compared with proton pump inhibitor in the maintenance of healed erosive esophagitis. JGH Open. 2024;8(3):e13053. Mody R, Bolge SC, Kannan H, Fass R. Effects of gastroesophageal reflux disease on sleep and outcomes. Clin Gastroenterol Hepatol. 2009;7(9):953-959.
